Programme Sponsored sessions

Friday May 5th - CEST Time zone

08:00 - 09:00
Auditorium B
AgNovos Healthcare Sponsored Breakfast Satellite Symposium - Addressing Local Bone Loss Through Targeted Bone Formation – From Theory to Clinical Practice Chairperson : Maria Luisa Brandi
  • Welcome & Introductions Maria Luisa Brandi
  • The Historical Role of Biomaterials to Form New Bone: What Have We Learned? Maria Luisa Brandi
  • Evidence Supporting the Role of a Surgical Approaches to Build Bone Andreas Kurth
  • Building a Multidisciplinary Care Pathway to Study a Surgical - Approach for Building New Bone in the Proximal Femur Ernesto Guerra Farfán
  • Adding a Surgical Treatment to a Clinical Practice in the Real-World Antoni Fraguas
  • Roundtable Discussion All
  • Open Q&A All
12:15 - 13:45
Auditorium A
UCB Sponsored Lunch Satellite Symposium - The fast path in osteoporosis treatment: Correcting the course Chairpersons : Maria Luisa Brandi & Laia Gifre
  • Welcome and introduction Laia Gifre, Maria Luisa Brandi
  • Bone-forming agents first: Embracing change in the treatment paradigm Erik Eriksen
  • Romosozumab first for patients at very high risk of fracture: Standing out from the crowd Serge Ferrari
  • Romosozumab first in practice: Clinical conundrums Erik Eriksen, Serge Ferrari
  • Q&A/discussion All
  • Conclusions and closing remarks Maria Luisa Brandi, Laia Gifre
12:15 - 13:45
Auditorium B
Viatris Sponsored Lunch Satellite Symposium - The importance of an early diagnosis and a holistic approach to treatment for the management of OA Chairperson : Jean-Yves Reginster
  • Welcome & Introduction Jean-Yves Reginster
  • The decade of healthy ageing, early diagnosis and early treatment Stefania Maggi
  • Why early treatment provides better opportunity to long term treatment success Nicholas Fuggle
  • Management of chronic pain in rheumatic diseases Frank Buttgereit
  • Q&A Session All
14:00 - 15:00
Room 123
IBSA Sponsored Meet-The-Expert Session - The economic burden of OA and the importance of cost-effective Treatments Chairperson : Olivier Bruyère
  • How can Health Economics help to optimize patient care in OA Mickaël Hiligsmann
  • An example of Health Economics evaluation: The case of I.A. HL-HA formulation Olivier Bruyère
  • Q&A session
17:00 - 18:30
Auditorium A
Theramex Sponsored Satellite Symposium - Abaloparatide, an innovative anabolic agent for the treatment of osteoporosis with increased risk of fracture Chairpersons : Jean-Yves Reginster & Cyrus Cooper
  • Welcome and Introduction Jean-Yves Reginster
  • Efficacy and tolerability of abaloparatide in postmenopausal women at risk of osteoporosis fracture Nicholas Harvey
  • Comparative effectiveness and cardiovascular safety of abaloparatide and teriparatide in postmenopausal women with osteoporosis in real world use Eugene McCloskey
  • Anabolic agents in the sequential treatment of osteoporosis Maria Luisa Brandi
  • Questions and Answers

Saturday May 6th - CEST Time zone

12:15 - 13:45
Auditorium B
AMGEN Sponsored Lunch Satellite Symposium - Addressing a data gap in osteoporosis: comparing clinical effectiveness of bisphosphonates and denosumab Chairperson : Xavier Nogues
  • Chair's Welcome Xavier Nogues
  • The Impact and Societal Burden of Nonvertebral Fractures Mattias Lorentzon
  • Clinical effectiveness of anti-resorptives for fracture risk reduction using the Medicare database Tzu-Chieh Lin
  • Short or long-term denosumab therapy to optimize fracture risk reduction Serge Ferrari
  • Panel discussion All
12:15 - 13:45
Auditorium A
Alexion Sponsored Lunch Satellite Symposium - Spotlight on hypophosphatasia: shining a light on your adult patients Chairperson : Kathryn Dahir
  • Spotlight on diagnosis and disease manifestations: what does HPP look like? - Shining a light on low alkaline phosphatase activity and genetic testing: how do they fit into the diagnosis? Carolina Tornero
  • Spotlight on diagnosis and disease manifestations: what does HPP look like? - How HPP may present in adult patients, and how to assess them? Kathryn Dahir
  • Spotlight on our clinics: what can we do about pediatric-onset HPP in adults? - Enzyme replacement therapy: experience from the UK Richard Keen
  • Spotlight on our clinics: what can we do about pediatric-onset HPP in adults? - Enzyme replacement therapy: what does it mean in the daily life of an adult patient with pediatric-onset HPP? Kathryn Dahir
  • Panel discussion All
  • Question and answer session All
  • Meeting close Kathryn Dahir
14:00 - 15:00
Room 130
Kyowa Kirin Sponsored Meet-The-Expert Session - Challenging the status quo: Management of adults with XLH
This event is intended for healthcare professionals who are registered for WCO-IOF-ESCEO 2023 only
  • Welcome, introduction and objectives Richard Keen
  • XLH - a multisystem disease: The importance of long-term integrated care Richard Keen
  • Ask the expert: Q&A on long-term integrated care Richard Keen
  • Real-world case studies of adults with XLH Richard Keen
  • Ask the expert: Q&A on real-world patient management Richard Keen
  • Summary and close Richard Keen

Sunday May 7th - CEST Time zone

09:00 - 10:00
Room 118
UCB Sponsored Meet-The-Expert Session - Identifying very high fracture risk patients in real-world clinical practice: Innovations and implications Chairperson/speaker : Maria Talla
  • Current post-fracture care pathway at NHS Greater Glasgow and Clyde (NHSGCC)
  • Optimising identification of very high fracture risk patients in the clinic
  • Innovations in fracture-risk evaluation